Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.
暂无分享,去创建一个
C. Napoli | L. Ignarro | J. Wallace | F. de Nigris | G. Caliendo | V. Santagada | F. Franconi | G. Cirino | C. Cicala | F. Nigris | Claudio Napoli | John Wallace
[1] C. Sobey,et al. Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation. , 1999, Stroke.
[2] J. Wallace,et al. Characterization of the inflammatory response to proteinase‐activated receptor‐2 (PAR2)‐activating peptides in the rat paw , 1999, British journal of pharmacology.
[3] M. Hollenberg. Protease-activated receptors: PAR4 and counting: how long is the course? , 1999, Trends in pharmacological sciences.
[4] J. Mehta,et al. Kinetics of tumor necrosis factor α in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor α in acute myocardial infarction , 1999 .
[5] A. Harken,et al. Inhibition of Myocardial TNF‐α Production by Heat Shock: A Potential Mechanism of Stress‐Induced Cardioprotection against Postischemic Dysfunction a , 1999, Annals of the New York Academy of Sciences.
[6] R. Sorrentino,et al. Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. , 1999, Circulation.
[7] M. Carr,et al. A protective role for protease-activated receptors in the airways , 1999, Nature.
[8] S. Zahler,et al. Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. , 1999, Circulation research.
[9] W. Fung-Leung,et al. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. , 1999, The Journal of pharmacology and experimental therapeutics.
[10] C. Napoli,et al. Age-related decrease in cardiac tolerance to oxidative stress. , 1999, Journal of molecular and cellular cardiology.
[11] T. Minami,et al. Increased vascular permeability by a specific agonist of protease‐activated receptor‐2 in rat hindpaw , 1998, British journal of pharmacology.
[12] C. Sobey,et al. Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. , 1998, Stroke.
[13] J. Hamilton,et al. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. , 1998, Circulation research.
[14] J. Hoxie,et al. Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells. , 1998, Arteriosclerosis, Thrombosis and Vascular Biology.
[15] D. Mann,et al. Tumor Necrosis Factor- (cid:97) Confers Resistance to Hypoxic Injury in the Adult Mammalian Cardiac Myocyte , 2022 .
[16] C. Napoli,et al. New-onset angina preceding acute myocardial infarction is associated with improved contractile recovery after thrombolysis. , 1998, European heart journal.
[17] S. M. Baker,et al. Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[18] C. Derian,et al. Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo. , 1998, Canadian journal of physiology and pharmacology.
[19] B. Walker,et al. Identification of potential activators of proteinase‐activated receptor‐2 1 , 1997, FEBS letters.
[20] D. Payan,et al. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. , 1997, The Journal of clinical investigation.
[21] J. Danesh,et al. Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.
[22] M. Hollenberg,et al. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Wahlestedt,et al. Vascular effects of proteinase-activated receptor 2 agonist peptide. , 1997, Journal of vascular research.
[24] C. Napoli,et al. A simple and rapid purification procedure minimizes spontaneous oxidative modifications of low density lipoprotein and lipoprotein (a). , 1997, Journal of biochemistry.
[25] P. Renesto,et al. Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. , 1997, Blood.
[26] J. Hoxie,et al. Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.
[27] V. Ramakrishnan,et al. The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial Cells , 1996, The Journal of Biological Chemistry.
[28] M. Hollenberg,et al. Rat proteinase‐activated receptor‐2 (PAR‐2): cDNA sequence and activity of receptor‐derived peptides in gastric and vascular tissue , 1996, British journal of pharmacology.
[29] Meeta Chatterjee,et al. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. , 1996, Circulation research.
[30] G. Wong,et al. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. , 1995, Journal of molecular and cellular cardiology.
[31] C. Wahlestedt,et al. Molecular cloning of a potential proteinase activated receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[32] N. Tsuji,et al. Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor. , 1992, Cancer research.
[33] G. Wong,et al. Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury , 1992 .
[34] H. Langstein,et al. Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats , 1991, Infection and immunity.
[35] A. A. Taylor,et al. Inflammation in the course of early myocardial ischemia , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] M. Weisfeldt,et al. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. , 1989, The Journal of biological chemistry.
[37] A. Harken,et al. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[38] D. Goeddel,et al. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.
[39] L. Becker,et al. Myocardial consequences of reperfusion. , 1987, Progress in cardiovascular diseases.
[40] H. Sies,et al. Energy‐linked cardiac transport system for glutathione disulfide , 1986, FEBS letters.
[41] Carl Wu. An exonuclease protection assay reveals heat-shock element and TATA box DNA-binding proteins in crude nuclear extracts , 1985, Nature.
[42] T. Ishikawa,et al. Cardiac transport of glutathione disulfide and S-conjugate. Studies with isolated perfused rat heart during hydroperoxide metabolism. , 1984, The Journal of biological chemistry.
[43] L. Harker,et al. Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. , 1984, The Journal of clinical investigation.
[44] T. Slater. Overview of methods used for detecting lipid peroxidation. , 1984, Methods in enzymology.
[45] B Chance,et al. Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.
[46] J. McCord. Free Radicals and Inflammation: Protection of Synovial Fluid by Superoxide Dismutase , 1974, Science.
[47] F. Tietze. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. , 1969, Analytical biochemistry.
[48] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.